Profile
| Metric | Value |
|---|---|
| Full Name | Braskem S.A. |
| Ticker | NYSE: BAK |
| Exchange | NYSE |
| Sector | Basic Materials |
| Industry | Chemicals |
| Country | Brazil |
| IPO | |
| Indexes | Not included |
| Website | braskem.com.br |
| Employees | 8,569 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $3.08 | |
| Price, 1D Change | +5.48% | |
| Market Cap | $1B | |
| TTM Dividend Yield | - | |
| PE Ratio | - | |
| Beta | 1.20 | |
| Revenue | $14B | |
| Revenue, 1Y Change | +1.64% | |
| EPS | -$5.27 | |
| EPS, 1Y Change | -128.98% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | $2.63 | |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 2:1 | |
| Next Split | N/A | N/A |
| Last Ticker Change | BRKMY | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| EPS | -$5.27 | |
| EPS Estimate | -$0.30 | |
| EPS Est. Change | +94.22% | |
| Revenue | $14.36B | |
| Revenue Estimate | $72.62B | |
| Revenue Est. Change | +405.74% | |
| Current Price | $3.08 | |
| Price Target | - | - |
| Price Tgt. Change | - | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$2.16 | -$2.30 | -6.51% | |
| -$2.84 | -$5.27 | -85.46% | |
| -$0.30 | N/A | +94.22% | |
| -$1.80 | N/A | +65.86% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $14.03B | $14.13B | +0.71% | |
| $79.11B | $14.36B | -81.85% | |
| $72.62B | N/A | +405.74% | |
| $78.19B | N/A | +444.54% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| Price, 1Y | -18.52% | |
| Price, 3Y | -65.43% | |
| Market Cap, 1Y | -18.52% | |
| Market Cap, 3Y | -65.40% | |
| Revenue, 1Y | +1.64% | |
| Revenue, 3Y | -26.64% | |
| EPS, 1Y | -128.98% | |
| EPS, 3Y | -181.02% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $3.08 | |
| SMA 200 | $3.20 | |
| SMA 200 vs Price | +3.73% | |
| SMA 50 | $2.85 | |
| SMA 50 vs Price | -7.47% | |
| Beta | 1.20 | |
| ATR | $0.16 | |
| 14-Day RSI | 57.71 | |
| 10-Day Volatility | 54.89% | |
| 1-Year Volatility | 64.84% |
Dividends
| Metric | Date | Value |
|---|---|---|
| Last Paid | $2.63 | |
| Upcoming | N/A | N/A |
| Dividend Yield | - | |
| Total Dividend | - | |
| Dividends Paid | $1.11M | |
| Payout Ratio | -0.05% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| Revenue | $14.36B | |
| EPS | -$5.27 | |
| Gross Profit | $1.11B | |
| Gross Margin | 7.75% | |
| Operating Profit | -$205.90M | |
| Operating Margin | -93.69% | |
| Net Income | -$2.24B | |
| Net Margin | -15.57% | |
| EBITDA | $712.31M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| Debt To Equity | -15.42 | |
| Current Ratio | 1.31 | |
| Quick Ratio | 0.83 | |
| - | ||
| F-Score | 2 | |
| Altman Z-Score | 0.78 |
Valuations
| Metric | Date | Value |
|---|---|---|
| PE Ratio | - | |
| PS Ratio | 0.09 | |
| PB Ratio | -4.27 | |
| EV/EBITDA | 88.47 | |
| Enterprise Value | N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| Book Value | -$335.04M | |
| Cash & Equivalents | $2.71B | |
| Total Assets | $16.44B | |
| Current Assets | $6.00B | |
| Total Liabilities | $17.13B | |
| Current Liabilities | $4.58B | |
| Total Debt | $11.93B | |
| Short Term Debt | $669.33M | |
| Accounts Payable | $2.73B |
Expenses
| Metric | Date | Value |
|---|---|---|
| Total Expenses | $16.46B | |
| Operating Expenses | $1.32B | |
| Cost Of Goods Sold | $13.25B | |
| SG&A | $0.00 | |
| D&A | $918.21M | |
| Interest Expense | $0.00 | |
| Income Tax | -$1.05B |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| CFO | $454.84M | |
| CFI | -$642.56M | |
| CFF | $79.95M | |
| Capex | $697.65M | |
| Free Cash Flow | -$242.81M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| UBS | → | |
| JP Morgan | → | |
| UBS | → | |
| JP Morgan | → | |
| Citigroup | → | |
| JP Morgan | → | |
| JP Morgan | → | |
| Scotiabank | → | |
| Scotiabank | → | |
| HSBC | → |
Analyst sentiment
Institutional ownership
Screeners with BAK
Data Sources & References
- BAK Official Website www.braskem.com.br
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1071438/000129281425003898/0001292814-25-003898-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1071438/000129281425001192/0001292814-25-001192-index.htm
- BAK Profile on Yahoo Finance finance.yahoo.com/quote/BAK
- BAK Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/bak
FAQ
What is the ticker symbol for Braskem S.A.?
The ticker symbol for Braskem S.A. is NYSE:BAK
Does Braskem S.A. pay dividends?
No, Braskem S.A. does not pay dividends
What sector is Braskem S.A. in?
Braskem S.A. is in the Basic Materials sector
What industry is Braskem S.A. in?
Braskem S.A. is in the Chemicals industry
What country is Braskem S.A. based in?
Braskem S.A. is headquartered in Brazil
When did Braskem S.A. go public?
Braskem S.A. initial public offering (IPO) was on January 13, 1999
Is Braskem S.A. in the S&P 500?
No, Braskem S.A. is not included in the S&P 500 index
Is Braskem S.A. in the NASDAQ 100?
No, Braskem S.A. is not included in the NASDAQ 100 index
Is Braskem S.A. in the Dow Jones?
No, Braskem S.A. is not included in the Dow Jones index
When was Braskem S.A. last earnings report?
Braskem S.A.'s most recent earnings report was on November 11, 2025
When does Braskem S.A. report earnings?
The next expected earnings date for Braskem S.A. is March 11, 2026